CHD - Church & Dwight Co., Inc.

NYSE - Nasdaq Real Time Price. Currency in USD
72.51
-1.17 (-1.59%)
As of 12:46PM EDT. Market open.
Stock chart is not supported by your current browser
Previous Close73.68
Open73.63
Bid72.49 x 900
Ask72.52 x 900
Day's Range72.51 - 74.07
52 Week Range57.25 - 80.99
Volume534,917
Avg. Volume1,617,715
Market Cap17.917B
Beta (3Y Monthly)0.03
PE Ratio (TTM)30.21
EPS (TTM)2.40
Earnings DateOct 31, 2019
Forward Dividend & Yield0.91 (1.24%)
Ex-Dividend Date2019-08-14
1y Target Est76.72
Trade prices are not sourced from all markets
  • Looking for a Growth Stock? 3 Reasons Why Church & Dwight (CHD) is a Solid Choice
    Zacks

    Looking for a Growth Stock? 3 Reasons Why Church & Dwight (CHD) is a Solid Choice

    Church & Dwight (CHD) could produce exceptional returns because of its solid growth attributes.

  • Can Procter & Gamble (PG) Beat on Earnings Again in Q1?
    Zacks

    Can Procter & Gamble (PG) Beat on Earnings Again in Q1?

    Procter & Gamble (PG) is likely to have witnessed positive trends in first-quarter fiscal 2020 on growth initiatives, including innovation, packaging and marketing efforts.

  • Hedge Funds Have Never Been More Bullish On Church & Dwight Co., Inc. (CHD)
    Insider Monkey

    Hedge Funds Have Never Been More Bullish On Church & Dwight Co., Inc. (CHD)

    With the first-quarter round of 13F filings behind us it is time to take a look at the stocks in which some of the best money managers in the world preferred to invest or sell heading into the second quarter. One of these stocks was Church & Dwight Co., Inc. (NYSE:CHD). Is Church & Dwight […]

  • Coca-Cola (KO) to Report Q3 Earnings: What Should You Expect?
    Zacks

    Coca-Cola (KO) to Report Q3 Earnings: What Should You Expect?

    Cola-Cola (KO) gains from the acceleration of sparkling soft drink category through investment and innovation. Further, its productivity and reinvestment program should drive growth.

  • PR Newswire

    Lifshitz & Miller LLP Announces Investigation of Church & Dwight Co., Fibrocell Science, Inc., MacroGenics, Inc., MINDBODY, Inc., PaySign, Inc., Zebra Technologies Corporation and Zynerbia Pharmaceuticals

    NEW YORK , Oct. 8, 2019 /PRNewswire/ -- Church & Dwight Co. (CHD) Lifshitz & Miller announces investigation into possible securities laws violations in connection with allegations of "significant ...

  • Why Church & Dwight (CHD) Could Beat Earnings Estimates Again
    Zacks

    Why Church & Dwight (CHD) Could Beat Earnings Estimates Again

    Church & Dwight (CHD) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

  • Moody's

    Church & Dwight Co., Inc. -- Moody's upgrades Church & Dwight to A3; outlook stable

    Moody's Investors Service ("Moody's") today upgraded Church & Dwight Co., Inc.'s ("Church & Dwight") senior unsecured ratings to A3 from Baa1 and affirmed the company's short term commercial paper rating at Prime-2. The upgrade reflects Church & Dwight's increasing scale, and improved product diversity over the past several years. The upgrade also reflects the company's strong execution of its growth strategy, as management has efficiently integrated acquisitions, while improving profitability and cash flow.

  • Top Ranked Growth Stocks to Buy for October 7th
    Zacks

    Top Ranked Growth Stocks to Buy for October 7th

    Top Ranked Growth Stocks to Buy for October 7th

  • Clorox (CLX) Introduces IGNITE Strategy, Trims FY20 Guidance
    Zacks

    Clorox (CLX) Introduces IGNITE Strategy, Trims FY20 Guidance

    Clorox (CLX) introduces IGNITE strategy, which is built on a sturdy foundation of its 2020 Strategy. It aims to innovate in all areas of the business. However, management lowers view for fiscal 2020.

  • Nu Skin's Customer Base Bodes Well, Mainland China is a Worry
    Zacks

    Nu Skin's Customer Base Bodes Well, Mainland China is a Worry

    Nu Skin (NUS) is battling headwinds in Mainland China that led to an unimpressive view for 2019. However, a rising customer base bodes well.

  • Lamb Weston (LW) Earnings Miss in Q1, Sales Improve Y/Y
    Zacks

    Lamb Weston (LW) Earnings Miss in Q1, Sales Improve Y/Y

    Lamb Weston's (LW) Q1 earnings and sales increase year over year, backed by improved volumes and price/mix across segments.

  • The Church & Dwight (NYSE:CHD) Share Price Is Up 118% And Shareholders Are Boasting About It
    Simply Wall St.

    The Church & Dwight (NYSE:CHD) Share Price Is Up 118% And Shareholders Are Boasting About It

    When you buy shares in a company, it's worth keeping in mind the possibility that it could fail, and you could lose...

  • 7 Stocks the Insiders Are Buying on Sale
    InvestorPlace

    7 Stocks the Insiders Are Buying on Sale

    [Editor's Note: This article is updated each week with the latest insider purchasing. Check back regularly to see who's making moves.]An insider is a person who has access to confidential information about a company. And when I'm analyzing a company as a potential long-term investment, I always like to know what the insiders are doing. They have a much better idea of what is happening in the company than most analysts. When there is insider buying after the price of the stock has recently dropped, it could be a bullish signal.Over the years, there have been numerous examples of insiders using this information to profit at the expense of uninformed investors. For example, suppose an insider knows that news is about to be released that will make the stock price go up. They can buy it from a shareholder who doesn't have access to the news at a cheaper price then benefit from the gains.InvestorPlace - Stock Market News, Stock Advice & Trading TipsBecause of these abuses, the SEC has established rules and procedures to prevent this type of activity. When an insider wants to buy or sell their company's stock, they have to file a form with the SEC. This is public information, and it can lead to investment ideas.There are numerous reasons why an insider of a company may need to sell their stock. They may need to raise money for things such as tuition or to buy a home. However, there is only one reason why an insider would buy their company's stock -- they believe that it is undervalued and they will make money. * 7 Stocks to Buy Under $10 These seven stocks have had significant insider buying recently and could be worth a look. Stocks With Insider Buying: Church & Dwight (CHD)Church & Dwight (NYSE:CHD) manufactures and sells household, personal care and specialty products.CHD stock has been under pressure recently. Well-known short seller Ben Axler of Spruce Point Capital Management said that the company engages is "extreme financial engineering, aggressive accounting and material self-enrichment practices." That sounds pretty bad.Matthew Farrell is the president and CEO of Church & Dwight. Apparently he disagrees with this assessment. He must believe that the stock will soon recover because he just made a significant personal investment of $500,000. He bought 7,000 shares at $71.32. Liberty TripAdvisor Holdings (LTRPA)Liberty TripAdvisor Holdings (NASDAQ:LTRPA) engages in online travel research and online commerce business.Over the past year, the price of LTRPA has fallen dramatically. Last November it traded as high as $20. Now it is trading below $10. Wall Street is neutral on the company. Only two firms follow it, and they each have hold ratings on it. * 30 Marijuana Stocks to Buy as the Future Turns Green Gregory Maffei has been an officer of Liberty for five years. He is the chairman, president and CEO of the company. He must feel that the stock is a great value at current levels, because he just invested $160,000 when he paid $10.38 a share for over 15,000 shares. Pacific Mercantile Bancorp (PMBC)Pacific Mercantile Bancorp (NASDAQ:PMBC) operates as a holding company that provides a range of commercial banking and services to small- and medium-sized businesses.After making a significant drop in price from last September through December, PMBC stock has been volatile but it has basically traded sideways.The Board of Directors just announced that they have appointed Brad Dinsmore as the president and CEO of the company. From 2011 to 2017, Dinsmore was executive vice president of SunTrust Banks.He must have a lot of confidence that he will be able to take actions that will cause the price of the stock to rise. He recently paid $7.98 for 28,000 shares. This is an investment of almost $225,000. Pennsylvania Real Estate Investment Trust (PEI)Pennsylvania Real Estate Investment Trust (NYSE:PEI) is a publicly traded REIT that owns and manages quality properties in compelling markets.PEI stock has sold off significantly over the past year. Last August it was trading around $11 a share. It is currently trading around the $5.50 level.Wall Street does not like this stock. Seven firms follow it. The average rating in underweight and the average price target is $5.25, which is below where it is currently trading. * 7 Triple-'F' Rated Stocks to Leave on the Shelf Leonard Korman is a director of PEI. Apparently he believes that the stock will turn around because he just paid $5.29 for 30,000 shares. In August he also bought 30,000 shares as well. His total investment was about $300,000. There was also buying by other insiders as well. Aldeyra Therapeutics (ALDX)Aldeyra Therapeutics (NASDAQ:ALDX) is a biotechnology company that develops and commercializes medicines for immune-mediated ocular and systemic diseases.ALDX stock has lost over 50% of its value in the past year. This isn't surprising because the company loses a lot of money. Last quarter it reported losses of $13 million and in the prior quarter the loss was more than $15 million.Todd Brady, the president and CEO of Aldeyra, invested roughly $85,000 into the company on Sept. 18, buying 14.288 shares at $5.91 per share. In addition, on Sept. 9 and Sept. 10 he paid an average of $5.14 for 20,000 shares. This was a $100,000 investment. Sarepta Therapeutics (SRPT)Sarepta Therapeutics (NASDAQ:SRPT) focuses of the discovery and development of medicines for rare diseases.Over the past two months, the price of SRPT stock has lost 50% of its value. It dropped from levels around $160 to current levels around $80.This is primarily due to the fact that the company received some disappointing news from the FDA. First, one of their drugs that is in a clinical trial caused serious side effects. Second, another drug has to be delayed beyond when it was supposed to hit the market. * 8 Dividend Stocks to Buy for a Recession Richard Barry is a director of the company. He must believe that this selling has created a buying opportunity. He just invested almost $290,000 when he bought 3,309 shares at $87.49. Lexicon Pharmaceuticals (LXRX)Lexicon Pharmaceuticals (NASDAQ:LXRX) is a biopharmaceutical company that develops and sells pharmaceutical products.The price of LXRX stock had been trending lower for almost a year. Then at the end of July it reported that its partnership with Sanofi (NASDAQ:SNY) had terminated the partnership and plunged from $6 to $2.The insiders of the company must believe that this selling was overdone because they have been making significant purchases of the stock.Lonnel Coats is the president and CEO of Lexicon Pharmaceuticals. He invested over $300,000 in the stock when he acquired 100,000 shares for an average price of around $3.11. Raymond Debbane is a director of the company. He just made an investment of about $700,000 when he bought about 290,000 shares. There have been purchases by other insiders as well.At the time of this writing Mark Putrino did not hold any positions in the aforementioned securities. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 7 Stocks to Buy Under $10 * 30 Marijuana Stocks to Buy as the Future Turns Green * 7 Consumer Stocks Ready to Rally Hard The post 7 Stocks the Insiders Are Buying on Sale appeared first on InvestorPlace.

  • Business Wire

    Church & Dwight to Report Third Quarter 2019 Results

    Church & Dwight Co., Inc. will host a conference call to discuss third quarter 2019 earnings results on October 31, 2019 at 10:00 a.m. Eastern time.

  • GuruFocus.com

    Weekly CEO Buys Highlight

    Insiders inveseted in Bausch Health Companies, SmileDirectClub, Church & Dwight, Liberty TripAdvisor Holdings and Athenex Continue reading...

  • Business Wire

    Waterpik® Enlists Dentist Chris Strandburg to Dispel Common Oral Care Myths

    According to a survey conducted by Waterpik® in collaboration with the American Dental Association, only 16 percent of Americans floss on a daily basis and 44 percent admit they have exaggerated to their dentist about how much they floss1. Church & Dwight Co., Inc, announced today that Waterpik® – the number one Water Flosser recommended by dental professionals – is joining forces with reality star and dentist Dr. Chris Strandburg to help Americans ‘get real’ about their oral care habits. In time for National Dental Hygiene Month in October, Dr. Strandburg is debunking oral care myths to empower self-professed ‘flossing failures’ and help them start a more honest relationship with their daily flossing routine.

  • Barrons.com

    Church & Dwight CEO Matthew Farrell Bought Stock After a Bearish Report Pummeled Shares

    The household-products giant’s shares have tumbled in recent weeks. CEO Farrell made the biggest insider stock purchase in years, and other insiders also bought Church & Dwight stock.

  • Business Wire

    ARM & HAMMER™ Delivers Innovation with New, Lightweight Laundry Solution

    With 76 percent of U.S consumers purchasing products online1, the need for lightweight, easy-to-ship options continues to be a growing need. ARM & HAMMER™ - the #1 value laundry brand2 – has an innovative, affordable solution: ARM & HAMMER™ Plus OxiClean™ Super Concentrated Liquid Laundry Detergent.

  • GlobeNewswire

    CHD INVESTOR ALERT: Hagens Berman Reminds Investors in Church & Dwight Co. (CHD) of Ongoing Investigation Involving Possible Securities Fraud

    SAN FRANCISCO, Sept. 17, 2019 -- Hagens Berman reminds investors of its ongoing investigation of Church & Dwight Co. (NYSE: CHD) concerning possible violations of the.

  • Procter & Gamble Stock: Valuation Limits Upside
    Market Realist

    Procter & Gamble Stock: Valuation Limits Upside

    Procter & Gamble stock trades at 24.7x its fiscal 2020 estimated core EPS of $4.85. The stock trades at 23.2x its fiscal 2021 estimated core EPS of $5.17.

  • Church & Dwight Stock: Valuation Overshadows Growth
    Market Realist

    Church & Dwight Stock: Valuation Overshadows Growth

    Church & Dwight (CHD) stock has risen 9.5% on a YTD (year-to-date) basis as of September 13. However, the stock lags its peers by a wide margin.

  • Is Church & Dwight Co., Inc.'s (NYSE:CHD) CEO Pay Justified?
    Simply Wall St.

    Is Church & Dwight Co., Inc.'s (NYSE:CHD) CEO Pay Justified?

    Matt Farrell has been the CEO of Church & Dwight Co., Inc. (NYSE:CHD) since 2016. This report will, first, examine the...

  • Church & Dwight up 9.2% in 6 Months, Strong Brands Add Gleam
    Zacks

    Church & Dwight up 9.2% in 6 Months, Strong Brands Add Gleam

    Church & Dwight's (CHD) robust brand portfolio is boosting market share across categories. However, weakness in the Specialty Products unit is a worry.

  • CHD INVESTOR ALERT: Hagens Berman Notifies Investors in Church & Dwight Co. (CHD) of an Investigation Involving Possible Securities Fraud
    PR Newswire

    CHD INVESTOR ALERT: Hagens Berman Notifies Investors in Church & Dwight Co. (CHD) of an Investigation Involving Possible Securities Fraud

    Class-action law firm urges CHD investors who have suffered more than $50K losses to learn their shareholder rights SAN FRANCISCO , Sept. 12, 2019 /PRNewswire/ -- Hagens Berman notifies investors that ...